Publications by authors named "Michael Press"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

500

Total Likes

15

Extended Reach

877

Social Features

3
I
Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci.
Guochong Jia, Jie Ping, Ran Tao, Jirong Long, Lili Liu, Michael F Press

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscapes of Endometrioid and Mucinous Ovarian Cancers and Morphologically Similar Tumor Types.
Dorothy Hallberg, Alice C Eastman, Shashikant Koul, Daniel C Bruhm, Eniko Papp, Michael F Press

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With a Food and Drug Administration-Approved Benchmark.
Sunil Badve, Jason S White, Francisco Sapunar, Kelli Thoele, Sameera R Wijayawardana, Michael F Press

Mod Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Ancestry Transcriptome-wide Association Studies Uncover New Insights into Breast Cancer Genetics and Biology.
Jie Ping, Guochong Jia, Qiuyin Cai, Xingyi Guo, Jifeng Wang, Michael F Press

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.
Dorothea Hanf, Peter Fasching, Paul Gass, Matthias W Beckmann, Carolin C Hack, Michael F Press

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.
Jamie E Medina, Akshaya V Annapragada, Pien Lof, Sarah Short, Adrianna L Bartolomucci, Michael F Press

Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining breast cancer genetic risk and biology through multi-ancestry fine-mapping analyses of 192 risk regions.
Guochong Jia, Zhishan Chen, Jie Ping, Qiuyin Cai, Ran Tao, Michael F Press

Nat Genet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer.
Xiaohui Sun, Shiv P Verma, Guochong Jia, Xinjun Wang, Jie Ping, Michael F Press

Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients.
Marius Wunderle, Felix Heindl, Annika S Behrens, Lothar Häberle, Carolin C Hack, Michael F Press

Arch Gynecol Obstet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes.
Jie Ping, Guochong Jia, Qiuyin Cai, Xingyi Guo, Ran Tao, Michael F Press

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction.
Guochong Jia, Jie Ping, Xingyi Guo, Yaohua Yang, Ran Tao, Michael F Press

Nat Genet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia.
Heather M Ochs-Balcom, Leah Preus, Zhaohui Du, Robert C Elston, Craig C Teerlink, Michael F Press

Hum Mol Genet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Annika Behrens, Lena Wurmthaler, Felix Heindl, Paul Gass, Lothar Häberle, Michael F Press

Geburtshilfe Frauenheilkd· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance of HER2 Expression and/or Amplification on Repeat Testing.
Timothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, Daniel D Karp, Jaffer A Ajani, Michael F Press

Mol Cancer Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of -Overexpressing Metastatic Breast Cancer.
Charles L Vogel, Melody A Cobleigh, Debu Tripathy, John C Gutheil, Lyndsay N Harris, Michael Press

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
Sanne L de Haas, Dennis J Slamon, Miguel Martin, Michael F Press, Gail D Lewis

Breast Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women.
Ugonna Ihenacho, Intira Sriprasert, Wendy J Mack, Ann S Hamilton, Jennifer B Unger, Michael F Press

Nicotine Tob Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study.
Ugonna Ihenacho, Ann S Hamilton, Wendy J Mack, Anna H Wu, Jennifer B Unger, Michael F Press

Breast Cancer Res Treat· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix PC1 System.
Evan N Cohen, Gitanjali Jayachandran, Richard G Moore, Massimo Cristofanilli, Julie E Lang, Michael F Press

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach.
Guimin Gao, Fangyuan Zhao, Thomas U Ahearn, Kathryn L Lunetta, Melissa A Troester, Michael F Press

Hum Mol Genet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer.
Adam L Maddox, Matthew S Brehove, Kiarash R Eliato, Andras Saftics, Eugenia Romano, Michael F Press

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Alexander Ring, Daniel Campo, Tania B Porras, Pushpinder Kaur, Victoria A Forte, Michael F Press

Ann Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Alexander Ring, Daniel Campo, Tania B Porras, Pushpinder Kaur, Victoria A Forte, Michael F Press

Ann Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone.
Monika D Polewski, Gitte B Nielsen, Ying Gu, Aaron T Weaver, Gavin Gegg, Michael F Press

Appl Immunohistochem Mol Morphol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis